Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-08 7:55 pm Purchase | 13D | Lomond Therapeutics Holdings Inc. | TPAV LLC | 2,729,672 10.000% | 2,729,672 (New Position) | View |
2024-11-08 7:54 pm Purchase | 13D | Lomond Therapeutics Holdings Inc. | Eilean Therapeutics LLC | 14,420,383 53.000% | 14,420,383 (New Position) | View |
2024-11-08 7:15 pm Purchase | 13D | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC | 2,677,256 9.800% | 2,677,256 (New Position) | View |
2024-11-08 5:00 pm Purchase | 13G | Lomond Therapeutics Holdings Inc. | BERDING JOHN B | 1,722,222 6.330% | 1,722,222 (New Position) | View |
2024-11-08 5:00 pm Purchase | 13G | Lomond Therapeutics Holdings Inc. | LINDNER S CRAIG | 1,722,222 6.330% | 1,722,222 (New Position) | View |
2024-11-08 5:00 pm Purchase | 13G | Lomond Therapeutics Holdings Inc. | AMERICAN FINANCIAL GROUP INC AFG | 1,722,222 6.330% | 1,722,222 (New Position) | View |
2024-11-08 4:49 pm Purchase | 13G | Lomond Therapeutics Holdings Inc. | Flynn James E | 2,692,625 9.900% | 2,692,625 (New Position) | View |
2023-02-13 5:22 pm Purchase | 13G | Lomond Therapeutics Holdings Inc. | Jacobs Ian Seth | 250,000 5.000% | 250,000 (New Position) | View |
2023-02-10 2:14 pm Purchase | 13G | Lomond Therapeutics Holdings Inc. | Tompkins Mark N. | 4,750,000 95.000% | 4,750,000 (New Position) | View |